Simvastatin prevents hypertrophy and keeps cardiac function in myocardium of rabbit with overlord by promoting PPAR gamma and inhibiting NF-kappa B

Chinese Pharmacological Bulletin

Volumn 26, Issue 1, 2010, Pages 115-119

  Qi, Hong Tao ^a,b   Liu, Zhi Hua ^a   Jiang, Bin ^a   Zou, Cao ^a   Zhao, Cai Ming ^a   Li, Hong Xia ^a   Han, Lian Hua ^a   Jiang, Ting Bo ^a   Song, Jian Ping ^a   Jiang, Wen Ping ^a  

^a SOOCHOW UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Congestive heart failure; Hypertrophy; NF B; PPAR gamma; Rabbit; Simvastatin

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIMVASTATIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA COARCTATION; AORTA VALVE REGURGITATION; ARTICLE; ASCENDING AORTA; BODY WEIGHT; CELL NUCLEUS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART VENTRICLE OVERLOAD; HEART WEIGHT; NONHUMAN; POSTOPERATIVE PERIOD; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 77951810194     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Schoonjans K, Martin G, Staels Auwerx J. Peroxisome proliferator- activated receptors, orphans with ligands and functions [J]. Curr Opin Lipidol, 1997,8(3):159-166 (Pubitemid 27290462)
2. Chawla A, Repa J J, Evans R M, et al. Nuclear receptors and lipid physiology : opening the X-files [J]. Science, 2001,294(5548):1866-1870 (Pubitemid 33101573)
3. Purcell N H ,Tang G L, Yu C F, et al. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes[J]. Proc Natl Acad Sci USA, 2001,98(12):6668-73.
4. Higuchi Y, Otsu K, Nishida S, et al. Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy[J]. J Mol Cell Cardiol, 2002,34(2):233-240
5. Asakawa M, Takano H, Nagai T, et al. Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo [J]. Circulation, 2002,105(10):1240-46. (Pubitemid 34225827)
6. Zou C, Liu Z H, Zhao C M, et al. A model of heart failure induced by volume plus pressure overload in rabbits [J]. Lab Anim Comp Med, 2005,4(25):248-254
7. Tian Q, Barger P M. Deranged energy substrate metabolism in the failing heart[ J]. Curr Hypertens Rep, 2006,8(6):465-471 (Pubitemid 44842772)
8. Barger P M, Brandt J M, Leone T C, et al. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth[J]. J Clin Invest, 2000,105(12):1723-1730
9. Yuan Z, Liu Y, Liu Y, et al. Cardioprotective effects of peroxisome proliferator activated receptor γ activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor κB blockade[J]. Heart, 2005,91(9):1203-1208 (Pubitemid 41192401)
10. Yamamoto K, Ohki R, Lee R, et al. Peroxisome proliferator-activated receptory activators inhibit cardiac hypertrophy in cardiac myocytes[J]. Circulation, 2001,104(14):1670-1675
11. Hirotani S, Otsu K, Nishida K, et al. Involvement of nuclear factor-Kappa B and apoptosis signal-regulating kinase 1 in G-protein- coupled receptor agonist-induced cardiomyocyte hypertrophy [J]. Circulation, 2002,105(4):509-515 (Pubitemid 34141710)
12. Li Y, Ha T, Gao X, et al. NF-κB activation is required for the development of cardiac hypertrophy in vivo[J]. Am J Physiol Heart Circ Physiol, 2004,287(4):H1712-20.
13. Xu X L, Qin S, Lei H, et al. Simvastatin ameliorates rat ventricular remodeling after myocardial infarction : the role of phosphorylating extracellular signal-regulated kinase1/2[J]. CAin Pharmacol Bull, 2008,24(2):258-261
14. Planavila A, Laguna J C, Väzquez-Carrera M. Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy preventing nuclear factor-κB activation [J]. Biochim Biophys Acta, 2005,1687(1-3):76-83. (Pubitemid 40228987)
15. Delerive P, De Bosscher K, Sandrine B, et al. Peroxisome proliferator-activated receptor a negatively regulates the vascular inflammatory gene response by negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1[J]. J Biol Chem, 1999,5274(45):32048-32054
16. Planavila A, Rodriguez-Calvo R, Jove M, et al. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes[J]. Cardiovasc Res, 2005,65(4):832-41.